Search

everythinglearnresearchcommunity

for

Search:↓

Papulopustular rosacea is an inflammatory skin condition treatable with lifestyle changes and medications.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Early balding at 40 increases prostate cancer risk.

Female pattern hair loss treatments vary in effectiveness and may have side effects.

Androgenetic alopecia is influenced by various factors and can be treated with medications, procedures, and non-drug methods.

Dutasteride injections can help hair growth in androgenic alopecia but need more research for long-term use.

Finasteride side effects in young men may be linked to specific gene variations.

Hair loss in balding individuals is linked to changes in specific hair growth-related genes.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

The document concludes that androgenetic alopecia is common, has a genetic link, and can be diagnosed and treated with medications like finasteride and minoxidil.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

A genetic variant in the androgen receptor gene increases heart disease risk in women but not in men.

Kennedy's disease leads to muscle weakness and sensory issues, has no cure but manageable symptoms, and future treatments look promising.

Society's pressure to have children later in life favors genes that increase the risk of early baldness in male offspring.

Women with greater androgen sensitivity respond better to finasteride for hair loss.

Certain gene variations are linked to better memory in healthy Chinese women.

The study suggests that a specific gene variation and higher gene activity are linked to increased baldness in Egyptian men.

A genetic test can identify people at risk of male pattern baldness early, allowing for quicker treatment.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

The conclusion is that adult males with muscle weakness and hormonal imbalances should be tested for Kennedy's disease.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

Hair loss needs more research for better treatments.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.

People with androgenetic alopecia may have a higher risk of severe COVID-19.

Flutamide improves female hair loss when other treatments fail, but may cause liver toxicity.

The PON1 192R gene variant is linked to a higher risk of psoriasis and heart disease in Western Mexico.

KGF and its receptor are found in enlarged prostate tissue and KGF strongly increases cell growth.

COVID-19 may worsen with androgens; anti-androgen drugs could help.